New drug hailed as ‘gamechanger’ in tackling stubbornly high blood pressure
Doctors are hailing a new pill for patients with high blood pressure resistant to existing medication as a “gamechanger” and a “triumph of science”,Globally, more than 1,3 billion people have hypertension,In half of them, their high blood pressure is uncontrolled or resistant to existing treatments,They face a much higher risk of heart attack, stroke, kidney disease and early death.
Now a blockbuster new drug – baxdrostat – has been shown in trials to significantly lower blood pressure in those people whose levels remain dangerously high despite taking several medicines,The results of the BaxHTN study, which involved 796 patients from 214 clinics worldwide, showed that after 12 weeks, patients taking baxdrostat saw their blood pressure fall by about 9-10 mmHg (millimetres of mercury, the unit of measurement of blood pressure) more than placebo – a reduction large enough to cut cardiovascular risk,About four in 10 patients taking the drug – 1mg (39,4%) or 2mg (40%) once daily in tablet form – reached healthy blood pressure levels, compared with fewer than two in 10 (18,7%) on placebo.
Details of the breakthrough against stubbornly high blood pressure were revealed at the European Society of Cardiology congress in Madrid, the world’s largest heart conference.Results from the trial, which was sponsored by AstraZeneca, were simultaneously published in the New England Journal of Medicine.Principal investigator Prof Bryan Williams, chair of medicine at UCL, said: “I’ve never seen blood pressure reductions of this magnitude with a drug.Achieving a nearly 10 mmHg reduction in systolic blood pressure with baxdrostat in the BaxHTN phase-3 trial is exciting, as this level of reduction is linked to substantially lower risk of heart attack, stroke, heart failure and kidney disease.“I think this could be a gamechanger in the way we approach difficult to control or hard to control blood pressure.
The results suggest that this drug could help up to half a billion people globally,”The breakthrough has taken decades of research to achieve,Blood pressure is strongly influenced by a hormone called aldosterone, which helps the kidneys regulate salt and water balance,Some people produce too much aldosterone, causing the body to hold on to salt and water,This aldosterone dysregulation pushes blood pressure up and makes it very difficult to control.
Tackling aldosterone dysregulation has been a key target of research over many years, but until now it has been impossible to achieve.Baxdrostat works by blocking aldosterone production, directly addressing this driver of high blood pressure.“This drug development is really a triumph of scientific discovery,” Williams told reporters at the conference in Madrid.“Aldosterone is a well-known driver of hypertension, but for decades, scientists have struggled to block its production in a precise way.Baxdrostat is one of the first therapies to do so selectively, showing meaningful BP [blood pressure] reductions in uncontrolled or resistant hypertension.
”Historically, wealthier western countries were reported to have greatly increased levels of high blood pressure,However, largely due to changing diets, the numbers of people living with hypertension is now far higher in eastern and lower-income countries,More than half of those affected live in Asia, including 226 million people in China and 199 million in India,Sign up to First ThingOur US morning briefing breaks down the key stories of the day, telling you what’s happening and why it mattersafter newsletter promotionProf Paul Leeson, a cardiologist and a professor of cardiovascular medicine at the University of Oxford, who was not involved with the trial, said the pill could become a “valuable additional treatment” to tackle high blood pressure,“For many years, we have had medications that are able to block aldosterone working but they do not actually lower levels of aldosterone, so patients may still experience adverse effects of the substance.
“Baxdrostat … is one version of a new range of medications that work differently, and directly reduce the levels of aldosterone.“Importantly, the trial was performed across several countries and included men and women, as well as patients with different ethnic backgrounds.This helps ensure the findings are relevant to the range of patients we see with blood pressure problems.”Separately, doctors in Madrid were told that a cholesterol-busting jab administered twice a year has the potential to transform heart care.New trial data presented at the conference suggested Leqvio, also known as inclisiran and made by Novartis, helped patients meet their cholesterol goals faster than other therapies.
Patients also experienced less muscle pain, a common side-effect of statins, the cholesterol-lowering medication.
Parents could get alerts if children show acute distress while using ChatGPT
Parents could be alerted if their teenagers show acute distress while talking with ChatGPT, amid child safety concerns as more young people turn to AI chatbots for support and advice.The alerts are part of new protections for children using ChatGPT to be rolled out in the next month by OpenAI, which was last week sued by the family of a boy who took his own life after allegedly receiving “months of encouragement” from the system.Other new safeguards will include parents being able to link their accounts to those of their teenagers and controlling how the AI model responds to their child with “age-appropriate model behaviour rules”. But internet safety campaigners said the steps did not go far enough and AI chatbots should not be on the market before they are deemed safe for young people.Adam Raine, 16, from California, killed himself in April after discussing a method of suicide with ChatGPT
AI industry pours millions into politics as lawsuits and feuds mount
Hello, and welcome to TechScape.A little over two years ago, OpenAI’s founder Sam Altman stood in front of lawmakers at a congressional hearing and asked them for stronger regulations on artificial intelligence. The technology was “risky” and “could cause significant harm to the world”, Altman said, calling for the creation of a new regulatory agency to address AI safety.Altman and the AI industry are promoting a very different message today. The AI they once framed as an existential threat to humanity is now key to maintaining American prosperity and hegemony
Meet Bus Aunty, the nurse turning London’s doubledeckers into a TikTok sensation
To her nearly 300,000 TikTok followers, she is Bus Aunty, the unlikely star of short videos that celebrate London’s streets and, above all, its doubledeckers. Now Bemi Orojuogun, 56, has urged her army of fans to share her appreciation for the hard-working bus drivers who keep the capital running.The mental health nurse has been overwhelmed by the response to the quirky, bite-size videos she began posting on social media last year. They feature clips of her standing at the roadside, sometimes at landmarks such as Trafalgar Square and Piccadilly Circus, as buses drive past.“My love for London red buses started a long time ago, when I first came to this country in the early 90s,” said Orojuogun, who is from Nigeria
Clanker! This slur against robots is all over the internet – but is it offensive?
Name: Clanker.Age: 20 years old.Appearance: Everywhere, but mostly on social media.It sounds a bit insulting. It is, in fact, a slur
The good and bad of machine learning | Letters
Imogen West-Knights is absolutely right about us losing our brain power to the artificial intelligence bots (ChatGPT has its uses, but I still hate it – and I’ll tell you why). I too believe creative imagination is a muscle, which needs its exercise. She is also right that it can revolutionise scientific endeavour. My field of weather forecasting will soon be revolutionised by machine learning – a type of AI – where we recognise enough past weather patterns so that we can predict what weather will be coming. But writing best-man speeches, leaving speeches for work colleagues, letters to a dear friend? Do we really want to dissolve into brain-lazy folk who use AI to be the understudy to our own emotions?If I say “I love you” to someone, would they like to hear it from me or a bot? There is also another concern: AI output has no audit trail, no clues to its source
Australian film-maker Alex Proyas: ‘broken’ movie industry needs to be rebuilt and ‘AI can help us do that’
At a time when capitalist forces are driving much of the advancement in artificial intelligence, Alex Proyas sees the use of AI in film-making as a source of artistic liberation.While many in the film sector see the emergence of artificial intelligence as a threat to their careers, livelihoods and even likenesses, the Australian film-maker behind The Crow, Dark City and I, Robot, believes the technology will make it much easier and cheaper to get projects off the ground.“The model for film-makers, who are the only people I really care about at the end of the day, is broken … and it’s not AI that’s causing that,” Proyas says. “It’s the industry, it’s streaming.”He says residuals that film-makers used to rely on between projects are drying up in the streaming era, and the budgets for projects becoming smaller
Hackers linked to M&S breach claim responsibility for Jaguar Land Rover cyber-attack
BoE’s Bailey plays down surge in 30-year borrowing costs, and criticises Trump’s attacks on the Fed – as it happened
Google will not be forced to sell Chrome, federal judge rules
Trump fortune balloons by billions after family firm’s crypto token starts trading
Djokovic unsure if he’ll be fit enough to beat Alcaraz in US Open semi-finals
US Open tennis 2025: Anisimova shocks Swiatek, Auger-Aliassime beats De Minaur on day 11 – live